Perspective Therapeutics, Inc. (CATX) Tops Q1 EPS by 5c

Perspective Therapeutics, Inc. (NYSE: CATX) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $76 thousand versus the consensus estimate of $157.38 thousand.

For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• Perspective Therapeutics Inc (CATX) PT Lowered to $5 at BofA Securities